Ole Thastrup

Gründer bei 2CUREX AB

73 Jahre

Health Technology

Consumer Non-Durables

Miscellaneous

Profil

Ole Thastrup is the founder of 2cureX ApS, founded in 2006, where the title held is Director & Chief Scientific Officer.
Dr. Thastrup is the founder of 2cureX AB, founded in 2006, where the title held is Chief Executive Officer & Director.
Dr. Thastrup is also the founder of Noapab Holdings A..
Dr. Thastrup is Chief Executive Officer & Director at Ot311 ApS.
Dr. Thastrup is a Member at Novo Nordisk Fonden.
Dr. Thastrup is Head-Drug Design Department & Professor at the University of Copenhagen.
Former positions include Principal at ZymoGenetics, Inc., Principal at Novo Nordisk A, and Head-Biosector at Carlsberg A from 2002 to 2006.

Aktive Positionen von Ole Thastrup

Unternehmen	Position	Beginn
2CUREX AB	Gründer	01.01.2006
2cureX ApS 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer	Gründer	01.01.2006
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Ot311 ApS	Vorstandsvorsitzender	-
Novo Nordisk Fonden Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation	Corporate Officer/Principal	-

Alle aktiven Positionen von Ole Thastrup

Ehemalige bekannte Positionen von Ole Thastrup

Unternehmen	Position	Ende
CARLSBERG A/S	Corporate Officer/Principal	01.01.2006
Noapab Holdings A/S Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products	Technik-/Wissenschafts-/F&E-Leiter	-
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs	Corporate Officer/Principal	-
NOVO NORDISK A/S	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Ole Thastrup im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ole Thastrup im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	9
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs	Health Technology
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Carlsberg A/S Carlsberg A/S Beverages: AlcoholicConsumer Non-Durables Produces and markets beers and soft drinks	Consumer Non-Durables
Novo Nordisk Fonden Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation	Miscellaneous
Noapab Holdings A/S Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products	Commercial Services
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
2cureX ApS 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer	Health Technology
2cureX AB 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices	Health Technology
Ot311 ApS